A study of docetaxel and irinotecan in children and young adults with recurrent or refractory Ewing sarcoma family of tumors

BACKGROUND: Patients with Ewing sarcoma family of tumors (ESFT) who are resistant even to salvage chemotherapy, have dismal prognoses and few therapeutic options. Because the docetaxel/irinotecan (DI) combination has not been previously evaluated in ESFT, we prospectively evaluated its use in patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Jong Hyung, Kwon, Mi Mi, Park, Hyeon Jin, Park, Seog Yun, Lim, Kun Young, Joo, Jungnam, Park, Byung-Kiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155244/
https://www.ncbi.nlm.nih.gov/pubmed/25164234
http://dx.doi.org/10.1186/1471-2407-14-622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155244/
https://www.ncbi.nlm.nih.gov/pubmed/25164234
http://dx.doi.org/10.1186/1471-2407-14-622

Ejemplares similares